These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The C-terminal fragment of substance P enhances dopamine release in nucleus accumbens but not in neostriatum in freely moving rats. Boix F, Huston JP, Schwarting RK. Brain Res; 1992 Oct 02; 592(1-2):181-6. PubMed ID: 1280516 [Abstract] [Full Text] [Related]
12. Effects of intranasally applied dopamine on behavioral asymmetries in rats with unilateral 6-hydroxydopamine lesions of the nigro-striatal tract. Pum ME, Schäble S, Harooni HE, Topic B, De Souza Silva MA, Li JS, Huston JP, Mattern C. Neuroscience; 2009 Aug 04; 162(1):174-83. PubMed ID: 19401223 [Abstract] [Full Text] [Related]
13. Striatal dopamine levels after unilateral lesions of the substantia nigra: evidence for a contralateral decrease. Hahn Z, Karádi Z, Lénárd L. Acta Physiol Acad Sci Hung; 1981 Aug 04; 57(3):249-53. PubMed ID: 6795897 [Abstract] [Full Text] [Related]
14. Behavioral asymmetries and neurochemical changes after unilateral lesions of tuberomammillary nucleus or substantia nigra. Maisonnette S, Huston JP, Brandao M, Schwarting RK. Exp Brain Res; 1998 Jun 04; 120(3):273-82. PubMed ID: 9628414 [Abstract] [Full Text] [Related]
15. Behavioral asymmetries and recovery in rats with different degrees of unilateral striatal dopamine depletion. Fornaguera J, Carey RJ, Huston JP, Schwarting RK. Brain Res; 1994 Nov 21; 664(1-2):178-88. PubMed ID: 7895027 [Abstract] [Full Text] [Related]
16. Neurotoxic action of 6-hydroxydopamine on the nigrostriatal dopaminergic pathway in rats sensitized with D-amphetamine. Nowak P, Kostrzewa RM, Kwieciński A, Bortel A, Labus Ł, Brus R. J Physiol Pharmacol; 2005 Jun 21; 56(2):325-33. PubMed ID: 15985712 [Abstract] [Full Text] [Related]
19. Intranigral substance P stimulation of striatal dopamine release is inhibited by spantide II: a new tachykinin antagonist without apparent neurotoxicity. Reid MS, Hökfelt T, Herrera-Marschitz M, Håkanson R, Feng DM, Folkers K, Goldstein M, Ungerstedt U. Brain Res; 1990 Nov 05; 532(1-2):175-81. PubMed ID: 1704289 [Abstract] [Full Text] [Related]
20. GDNF protects against 6-OHDA nigrostriatal lesion: in vivo study with microdialysis and PET. Opacka-Juffry J, Ashworth S, Hume SP, Martin D, Brooks DJ, Blunt SB. Neuroreport; 1995 Dec 29; 7(1):348-52. PubMed ID: 8742486 [Abstract] [Full Text] [Related] Page: [Next] [New Search]